Effective therapies exist for managing relapsing/remitting MS, but treatment for progressive MS has proved more challenging. Now, a new article has identified potential mechanisms that may inform the development of therapies that effectively manage progressive MS.
Differences in MS patients’ cerebrospinal fluid may be key to drugs that halt progression
Effective therapies exist for managing relapsing/remitting MS, but treatment for progressive MS has proved more challenging. Now, a new article has identified potential mechanisms that may inform the development of therapies that effectively manage progressive MS.